Technical Analysis for TH - Theratechnologies Inc.

Grade Last Price % Change Price Change
grade F 4.9 -0.81% -0.040
TH closed down 0.81 percent on Friday, October 11, 2019, on 39 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical TH trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Calm After Storm Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Inside Day Range Contraction 0.00%
Calm After Storm Range Contraction -0.81%
Lower Bollinger Band Walk Weakness -0.81%
Stochastic Reached Oversold Weakness -0.81%
Below Lower BB Weakness -0.81%

Older signals for TH ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Theratechnologies Inc. is a specialty pharmaceutical company. The Company addresses medical needs to promote healthy living among human immunodeficiency virus (HIV) patients. Its products include EGRIFTA and Ibalizumab. EGRIFTA (tesamorelin for injection) refers to tesamorelin and it is indicated for the reduction of excess abdominal fat in HIV infected patients with lipodystrophy. EGRIFTA is indicated for the treatment of excess visceral adipose tissue (VAT), as assessed by waist circumference of approximately 100 centimeters for males and approximately 90 centimeters for females. Ibalizumab is a cluster difference 4 (CD4)-directed HIV entryinhibitor, which focuses on treating multidrug resistant HIV-1 infection (MDR HIV-1). ibalizumab binds to the second extracellular domain of the CD4 receptor. Ibalizumab has completed the Phase III trial. EGRIFTA is available in Canada and in the United States. The Company distributes EGRIFTA in the United States through RxC Acquisition Company.
Medical Specialties Pharmaceutical Immunology Organ Systems Infection Hiv
Is TH a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 9.74
52 Week Low 4.71
Average Volume 72,225
200-Day Moving Average 6.8139
50-Day Moving Average 5.3986
20-Day Moving Average 5.465
10-Day Moving Average 5.27
Average True Range 0.301
ADX 18.56
+DI 17.5672
-DI 26.3117
Chandelier Exit (Long, 3 ATRs ) 5.117
Chandelier Exit (Short, 3 ATRs ) 5.613
Upper Bollinger Band 6.0807
Lower Bollinger Band 4.8493
Percent B (%b) 0.04
BandWidth 22.532479
MACD Line -0.1241
MACD Signal Line -0.0458
MACD Histogram -0.0783
Fundamentals Value
Market Cap 367.12 Million
Num Shares 74.9 Million
EPS -0.20
Price-to-Earnings (P/E) Ratio -24.50
Price-to-Sales 13.99
Price-to-Book 12.44
PEG Ratio -191.68
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.080
Resistance 3 (R3) 5.100 5.060 5.050
Resistance 2 (R2) 5.060 5.014 5.050 5.040
Resistance 1 (R1) 4.980 4.986 4.960 4.960 5.030
Pivot Point 4.940 4.940 4.930 4.930 4.940
Support 1 (S1) 4.860 4.894 4.840 4.840 4.770
Support 2 (S2) 4.820 4.866 4.810 4.760
Support 3 (S3) 4.740 4.820 4.750
Support 4 (S4) 4.720